Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Aehr Test Systems’s stock clocked out at $10.59, up 2.22% from its previous closing price of $10.36. In other words, the price has increased by $2.22 from its previous closing price. On the day, 0.91 million shares were traded. AEHR stock price reached its highest trading level at $10.75 during the session, while it also had its lowest trading level at $10.19.
Ratios:
To gain a deeper understanding of AEHR’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 67.88. For the most recent quarter (mrq), Quick Ratio is recorded 5.91 and its Current Ratio is at 10.06. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 18 ’24 when Erickson Gayn sold 4,871 shares for $17.39 per share. The transaction valued at 84,726 led to the insider holds 427,935 shares of the business.
ROGERS VERNON sold 1,309 shares of AEHR for $22,769 on Jan 18 ’24. The Exec VP of Sales & Mktg. now owns 40,277 shares after completing the transaction at $17.39 per share. On Jan 18 ’24, another insider, RICHMOND DONALD P. II, who serves as the CTO of the company, sold 1,021 shares for $17.39 each. As a result, the insider received 17,759 and left with 175,232 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEHR now has a Market Capitalization of 306206688 and an Enterprise Value of 264931984. As of this moment, Aehr’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.44, and their Forward P/E ratio for the next fiscal year is 20.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.26 while its Price-to-Book (P/B) ratio in mrq is 3.54. Its current Enterprise Value per Revenue stands at 3.685 whereas that against EBITDA is 19.257.
Stock Price History:
The Beta on a monthly basis for AEHR is 2.01, which has changed by -0.5611272 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, AEHR has reached a high of $54.10, while it has fallen to a 52-week low of $10.27. The 50-Day Moving Average of the stock is -26.97%, while the 200-Day Moving Average is calculated to be -63.88%.
Shares Statistics:
It appears that AEHR traded 1.35M shares on average per day over the past three months and 1140330 shares per day over the past ten days. A total of 28.54M shares are outstanding, with a floating share count of 27.11M. Insiders hold about 6.25% of the company’s shares, while institutions hold 67.76% stake in the company. Shares short for AEHR as of 1711584000 were 5610102 with a Short Ratio of 4.15, compared to 1709164800 on 5964108. Therefore, it implies a Short% of Shares Outstanding of 5610102 and a Short% of Float of 20.49.
Earnings Estimates
The dynamic stock of Aehr Test Systems (AEHR) is currently attracting attention from 2 analysts actively involved in rating its market status.On average, analysts expect EPS of $0.1 for the current quarter, with a high estimate of $0.11 and a low estimate of $0.1, while EPS last year was $0.23. The consensus estimate for the next quarter is $0.09, with high estimates of $0.09 and low estimates of $0.09.
Analysts are recommending an EPS of between $0.48 and $0.48 for the fiscal current year, implying an average EPS of $0.48. EPS for the following year is $0.53, with 2 analysts recommending between $0.58 and $0.48.
Revenue Estimates
In the current quarter, 2 analysts expect revenue to total $15.44M. It ranges from a high estimate of $15.5M to a low estimate of $15.38M. As of the current estimate, Aehr Test Systems’s year-ago sales were $22.27M, an estimated decrease of -30.70% from the year-ago figure.
A total of 2 analysts have provided revenue estimates for AEHR’s current fiscal year. The highest revenue estimate was $65.12M, while the lowest revenue estimate was $65.09M, resulting in an average revenue estimate of $65.11M. In the same quarter a year ago, actual revenue was $64.96M, up 0.20% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $67.86M in the next fiscal year. The high estimate is $70.6M and the low estimate is $65.12M. The average revenue growth estimate for next year is up 4.20% from the average revenue estimate for this year.
